Coverage
-
March 13, 2014
A Delaware magistrate judge urged the court on Thursday toss a shareholder derivative suit claiming Allergan Inc.'s directors gave investors misleading information about a proposed executive bonus plan, saying the pharmaceutical company's motion to dismiss should be granted on "demand futility" grounds.
2 other articles on this case.
View all »